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1) Background 
In a group of 138 adults with Type 1 
diabetes in the UK, DAFNE training in 
flexible intensive insulin therapy 
significantly reduced the negative impact 
of diabetes on quality of life (QoL) and 
improved blood glucose (BG) control 
without significantly increasing severe 
hypoglycaemia or body mass index (BMI)1. 
Despite positive results overall, it was 
evident that there was wide variation in 
some outcomes [Table 1], particularly 
body weight.  DAFNE has the potential to 
improve a range of outcomes but it is 
important that improvements in particular 
outcomes are not achieved at the expense 
of others. 
Analyses were conducted to predict who 
would benefit most from the generally 
highly successful DAFNE training and who 
might experience undesirable effects. 
2) Methods 
Questionnaires were completed at 
baseline and 6-months post-training: 
 Demographic 
 Biomedical 
 ADDQoL2 (measure of the impact of 
diabetes on QoL) 
 DTSQ3 (Diabetes Treatment 
Satisfaction Questionnaire) - extended 
version 
 W-BQ284 (measure of generic and 
diabetes-specific well-being) 
 ADDLoC5 (measure of diabetes-specific 
locus of control) 
Multiple regression was used to predict 
change in outcomes (6 months post- 
DAFNE) for 125 (90.6%) participants using 
baseline data. 
Table 1: Change in outcomes 6 months 
              post-training  3) Results & Discussion 
Improvement in QoL [Table 2] was 
predicted by greater dietary restriction at 
baseline and lower treatment satisfaction.  
Improvement in HbA1c [Table 3] was 
predicted by higher BG levels and fewer 
perceived hypoglycaemic episodes at 
baseline. Expectations (perhaps reflecting 
greater optimism or determination) were 
also important as was higher BMI. 
Predicting improvement in BMI [Table 4] 
was more complex.  Improvement was 
predicted most reliably by greater negative 
impact of diabetes on dietary freedom at 
baseline.  This indicates that those who 
perceived least dietary freedom prior to 
DAFNE put on most weight post-DAFNE.  
The influence of training centre will have 
involved messages (e.g. healthy eating) 
conveyed by Educators before and during 
DAFNE.  Finally, those who gained weight 
reported less satisfaction with the 
effectiveness, flexibility and convenience 
of insulin at baseline. 
4) Conclusions 
Final regression models predicted up to 
30% of the variance in outcomes. Lifting 
dietary restrictions had benefits for QoL 
but also contributed to the prediction of 
weight gain.  As expected, those with 
greatest improvement in BG levels were 
those with higher BG levels and fewer 
hypoglycaemic episodes at baseline; they 
also had greater expectations of DAFNE. 
While DAFNE was successful overall, 
outcomes are likely to be maximised for 
individuals if their expectations and 
personal goals are considered by DAFNE 
Educators, who also warn participants 
about the risks of unwanted outcomes. 
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*  Average Weighted Impact of diabetes on QoL 
** Haemoglobin A1c = average blood glucose over approx. 2 months 
Change score:       N       mean    SD    median   min.   max. 
ADDQoL AWI*      123      0.56     1.14     0.39      -2.94   7.38 
HbA1c (%)**           125    -0.84     1.12    -0.80      -4.00   1.50 
Weight (kg)           125      0.53     2.77     0.40      -5.70   8.00 
Table 2: Prediction of improvement in 
              ADDQoL AWI scores 
R2=0.210 (Adjusted R2=0.191)                              * p<0.05, **** p<0.0001 
Predictor                                                  B                      F 
‘Freedom to eat as I wish’                  -0.033          16.3**** 
(ADDQoL item 18) 
‘Treatment Satisfaction’                       -0.096            5.3* 
(DTSQ total score) 
Table 3: Prediction of improvement in 
              blood glucose levels (HbA1c) 
R2=0.301 (Adjusted R2=0.276)                              * p<0.05, **** p<0.0001 
Predictor                                                  B                      F 
HbA1c                                                     -0.373          20.8**** 
‘Perceived frequency of hypo-            0.166            5.0* 
glycaemia’ (DTSQ item 3) 
‘Expectations’ of DAFNE                    -0.012            4.8* 
(immediately following course) 
BMI                                                          -0.037            4.7* 
Table 4: Prediction of improvement in 
              body mass index (BMI) 
R2=0.301 (Adjusted R2=0.276)                              * p<0.05, **** p<0.0001 
a parameter set to zero because it is redundant 
Predictor                                                  B                      F 
‘Freedom to eat as I wish’                   0.103          10.0** 
(ADDQoL item 18) 
Training centre                                                              6.6** 
= Kings                                                     0.487 
= Sheffield                                              -0.285 
= Northumbria                                         0.0a 
‘Satisfaction with  insulin’                      0.031            4.1* 
(Extended DTSQ subscale) 
 
